BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 35561968)

  • 1. Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.
    Pollock NR; Harrison GF; Norman PJ
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1763-1775. PubMed ID: 35561968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
    Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
    PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the killer cell immunoglobulin-like receptor system.
    Rajalingam R
    Methods Mol Biol; 2012; 882():391-414. PubMed ID: 22665247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer-cell immunoglobulin-like receptors on the cusp of modern immunogenetics.
    Colucci F; Traherne J
    Immunology; 2017 Dec; 152(4):556-561. PubMed ID: 28755388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; OrrĂ¹ G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.
    Parham P; Norman PJ; Abi-Rached L; Guethlein LA
    Philos Trans R Soc Lond B Biol Sci; 2012 Mar; 367(1590):800-11. PubMed ID: 22312047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.
    Deng Z; Zhen J; Harrison GF; Zhang G; Chen R; Sun G; Yu Q; Nemat-Gorgani N; Guethlein LA; He L; Tang M; Gao X; Cai S; Palmer WH; Shortt JA; Gignoux CR; Carrington M; Zou H; Parham P; Hong W; Norman PJ
    Mol Biol Evol; 2021 May; 38(6):2582-2596. PubMed ID: 33616658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.
    Guinan KJ; Cunningham RT; Meenagh A; Gonzalez A; Dring MM; McGuinness BW; Middleton D; Gardiner CM
    Genes Immun; 2010 Sep; 11(6):467-78. PubMed ID: 20200544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yin and Yang of HLA and KIR in human disease.
    Kulkarni S; Martin MP; Carrington M
    Semin Immunol; 2008 Dec; 20(6):343-52. PubMed ID: 18635379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR genes and HLA class I ligands in Gaucher disease.
    Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
    Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
    Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
    Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.
    Varbanova V; Naumova E; Mihaylova A
    Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR/HLA interactions and pathogen immunity.
    Jamil KM; Khakoo SI
    J Biomed Biotechnol; 2011; 2011():298348. PubMed ID: 21629750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primate-specific regulation of natural killer cells.
    Parham P; Abi-Rached L; Matevosyan L; Moesta AK; Norman PJ; Older Aguilar AM; Guethlein LA
    J Med Primatol; 2010 Aug; 39(4):194-212. PubMed ID: 20618586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
    Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
    Front Immunol; 2020; 11():561553. PubMed ID: 33178188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.